Cytek Biosciences (CTKB) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cytek Biosciences Price Target Cut to $8.00/Share From $8.50 by Piper Sandler
Dow JonesMar 4 10:56 ET · Ratings
Cytek Biosciences Is Maintained at Overweight by Piper Sandler
Dow JonesMar 4 10:56 ET · Ratings
Cytek Biosciences Analyst Ratings
BenzingaMar 4 10:44 ET · Ratings
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8
Moomoo NewsMar 4 07:31 ET · Ratings
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation?
Yahoo FinanceMar 1 08:36 ET
Cytek Biosciences | 10-K: FY2024 Annual Report
SECFeb 28 12:34 ET · Announcements

Comments

Stock_Drift

Nov 19, 2024 16:44

$Cytek Biosciences (CTKB.US)$

Jaguar8

Nov 7, 2024 16:03

NEWS

$Cytek Biosciences (CTKB.US)$
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Cytek Biosciences (CTKB) has launched the world's first Enhanced Small Particle (ESP™) Detection Option for its Aurora™ CS cell sorter system. This groundbreaking technology enables detection and sorting of particles as small as 70 nm, including exosomes and extracellular vesicles (EVs). The system builds on Cytek's Full Spectrum Profiling™ technology and al...

Leon97

Nov 7, 2024 09:52

Flyyyyyyy

$Cytek Biosciences (CTKB.US)$ Up Up Up

2

Jaguar8

May 28, 2024 16:31

NEWS

$Cytek Biosciences (CTKB.US)$
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
On May 28, 2024, Cytek Biosciences (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails received approval from China's National Medical Products Administration (NMPA) for clinical use. These reagents, used in the Cytek Northern Lights-Clinical (NL-CLC) cell analysis systems, aid in diagnosing and monitoring immune-related conditions...

2

Jaguar8

May 20, 2024 16:46

$Cytek Biosciences (CTKB.US)$
NEWS
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences has introduced the Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ systems. This upgrade allows researchers to detect subcellular particles, such as extracellular vesicles (EVs), with superior sensitivity and resolution. The global EV market is projected to grow significantly, from $227.5...

CTKB Cytek Biosciences

Trade Overview

Capital Trend

News

Comments

Trending Stocks